Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera maintenance in chronic renal anemia
NCT00550680Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2008
- Primary completion
- Sep 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease, sponsored by Roche. Started Jan 2008; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT00550680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550680.